Kriya Therapeutics

Developing gene therapies for prevalent chronic diseases.

Founded 2019 · 189 employees · United States · Private

Funding:

Series D · $320M · 2025

Subsidiaries:

Redpin Therapeutics, Tramontane Therapeutics